We added the SRF/MRTF pathway inhibitor CCG-203971 (CCG) to the 3D hypoglycemic model to evaluate the functional role of SRF/MRTF-A in ECM utilization and AD-like neurodegeneration. Here, SRF is linked to Alzheimer disease.